Tectonic Therapeutic, Inc. (TECX) Stock Forecast & Price Target
Tectonic Therapeutic, Inc. · NASDAQ
$30.62+0.25 (+0.82%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Tectonic Therapeutic, Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $75.00 to $81.00, so the covering firms are broadly aligned. The average target of $78.00 sits 155% above the current $30.62. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.37 next quarter toward $-5.68 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy125%
Buy375%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Tectonic Therapeutic, Inc.
As of Jul, 4 of 4 firms rate TECX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TECX EPS & revenue forecast
EPS · NEXT QUARTER
$-1.37
Range $-1.53 – $-1.23 · 8 analysts · +34% YoY
Next period, 8 analysts expect Tectonic Therapeutic, Inc. to earn $-1.37 a share (range $-1.53 – $-1.23), versus $-1.02 a year earlier. Full-year consensus is $-5.32, growing to $-5.68 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 8 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Tectonic Therapeutic, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TECX.
#1
Yasmeen Rahimi
Piper Sandler · Rank #152
Buy
$76.00+148.2% to target
Overall win rate
34%
+ Follow
#2
MF
Michael Freeman
Raymond James
Buy
$81.00+164.5% to target
Coverage
—
+ Follow
#3
JC
James Condulis
Stifel
Buy
$75.00+144.9% to target
Coverage
—
+ Follow
#4
DB
Danielle Brill
Truist Securities
Buy
$60.00+96.0% to target
Coverage
—
+ Follow
#5
Tyler Van Buren
TD Cowen
Buy
No targeton TECX
Coverage
—
+ Follow
TECX stock forecast FAQ
What is TECX's average 12-month price target?+
The 2 analysts with a live target average $78.00 for Tectonic Therapeutic, Inc. over the next 12 months, ranging from a $81.00 high to a $75.00 low.
Is TECX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TECX?+
The Street-high target is $81.00 (Raymond James), and the Street-low is $75.00 (Stifel). The average of all 2 active targets is $78.00.
How many Wall Street analysts cover TECX?+
4 analysts have an active rating on Tectonic Therapeutic, Inc., and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering TECX?+
Among analysts who currently cover TECX, Yasmeen Rahimi of Piper Sandler has the strongest overall Quantellect track record (Rank #152). Their current call is Buy with a $76.00 target.
What is Tectonic Therapeutic, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-1.37 per share (range $-1.53 – $-1.23) across 8 analysts. Full-year EPS is projected at $-5.32, rising to $-5.68 the following year.
How much revenue is Tectonic Therapeutic, Inc. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading TECX lately?+
As of Jul, 4 of 4 firms rate TECX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TECX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
